Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Glassia
1.2.3 Aralast NP
1.2.4 Prolastin C
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2020-2031)
2.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
2.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2020-2025)
2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2026-2031)
2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2020-2025)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2024
3.5 Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy Head office and Area Served
3.6 Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy, Product and Application
3.7 Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2020-2025)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2026-2031)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2020-2025)
5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2020-2031)
6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025)
6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2020-2031)
7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025)
7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2020-2031)
8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2020-2031)
9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025)
9.4 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2020-2031)
10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.1.5 Grifols Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Kamada
11.4.1 Kamada Company Details
11.4.2 Kamada Business Overview
11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.4.5 Kamada Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.5.5 Takeda Recent Development
11.6 Abeona
11.6.1 Abeona Company Details
11.6.2 Abeona Business Overview
11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
11.6.5 Abeona Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Glassia
Table 3. Key Players of Aralast NP
Table 4. Key Players of Prolastin C
Table 5. Key Players of Others
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2020-2025)
Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2026-2031)
Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players (2020-2025)
Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2024)
Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy, Headquarters and Area Served
Table 22. Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy, Product and Application
Table 23. Global Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Grifols Company Details
Table 49. Grifols Business Overview
Table 50. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 51. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 52. Grifols Recent Development
Table 53. CSL Company Details
Table 54. CSL Business Overview
Table 55. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 56. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Baxter Company Details
Table 59. Baxter Business Overview
Table 60. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 61. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 62. Baxter Recent Development
Table 63. Kamada Company Details
Table 64. Kamada Business Overview
Table 65. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 66. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 67. Kamada Recent Development
Table 68. Takeda Company Details
Table 69. Takeda Business Overview
Table 70. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 71. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 72. Takeda Recent Development
Table 73. Abeona Company Details
Table 74. Abeona Business Overview
Table 75. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 76. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025) & (US$ Million)
Table 77. Abeona Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
Table 81. Authors List of This Report


List of Figures
Figure 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Picture
Figure 2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2024 VS 2031
Figure 4. Glassia Features
Figure 5. Aralast NP Features
Figure 6. Prolastin C Features
Figure 7. Others Features
Figure 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2024
Figure 17. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2024
Figure 19. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2020-2031)
Figure 21. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2020-2031)
Figure 25. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2020-2031)
Figure 33. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 49. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 50. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 51. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 52. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 53. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit